Andrew Shaw

Andrew Shaw has a diverse work experience in various fields. Andrew spent eight years as the Founder and Director of Research at EvanesCo Ltd, contributing to their research and development efforts. Andrew also served as the Founder and Director of Research at Attomarker Ltd, where they played a key role in developing a new multiplexed blood testing technology. As the CEO and Founder of Attomarker, they spearheaded the company's mission to revolutionize population health management through accurate blood testing in remote communities and homes. Additionally, Andrew held the position of Associate Professor of Physical Chemistry at the University of Exeter, where their research focused on accurate measurements and the development of techniques for profiling biological systems. Andrew also served as the Chairman of Arkiris, a joint initiative with QinetiQ and the University of Exeter, aimed at commercializing tailored electromagnetic materials inspired by the nanostructures found in butterfly wings.

Andrew Shaw has a Bachelor's degree in Natural Sciences from the University of Cambridge. Andrew then pursued a PhD in Gas Phase Physical Chemistry at the University of Southampton, which they completed between 1989 and 1992. It is not mentioned if they obtained any further degrees or conducted any specific studies at Stanford University.